These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 29500241

  • 21. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
    [Abstract] [Full Text] [Related]

  • 22. Molecular Studies and an ex vivo Complement Assay on Endothelium Highlight the Genetic Complexity of Atypical Hemolytic Uremic Syndrome: The Case of a Pedigree With a Null CD46 Variant.
    Piras R, Iatropoulos P, Bresin E, Todeschini M, Gastoldi S, Valoti E, Alberti M, Mele C, Galbusera M, Cuccarolo P, Benigni A, Remuzzi G, Noris M.
    Front Med (Lausanne); 2020 Feb; 7():579418. PubMed ID: 33224962
    [Abstract] [Full Text] [Related]

  • 23. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome.
    Sugawara Y, Kato H, Nagasaki M, Yoshida Y, Fujisawa M, Minegishi N, Yamamoto M, Nangaku M.
    J Hum Genet; 2023 Jun; 68(6):427-430. PubMed ID: 36755127
    [Abstract] [Full Text] [Related]

  • 24. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 25. CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.
    Piras R, Valoti E, Alberti M, Bresin E, Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2022 Oct; 13():1011580. PubMed ID: 36793547
    [Abstract] [Full Text] [Related]

  • 26. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication.
    Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T.
    Front Immunol; 2024 Oct; 15():1360855. PubMed ID: 38524137
    [Abstract] [Full Text] [Related]

  • 27. Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy.
    Haydock L, Garneau AP, Tremblay L, Yen HY, Gao H, Harrisson R, Isenring P.
    J Mol Med (Berl); 2022 Feb; 100(2):269-284. PubMed ID: 34714369
    [Abstract] [Full Text] [Related]

  • 28. Anti-factor B antibodies in atypical hemolytic uremic syndrome.
    Khandelwal P, Nambiar S, Saini R, Saini S, Coshic P, Sinha A, Hari P, Palanichamy JK, Bagga A.
    Pediatr Nephrol; 2024 Jun; 39(6):1909-1916. PubMed ID: 38252289
    [Abstract] [Full Text] [Related]

  • 29. Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome.
    Khandelwal P, Joshi A, Mathur A, Puraswani M, Gurjar BS, Sinha A, Hari P, Faruq M, Bagga A.
    Pediatr Nephrol; 2023 Aug; 38(8):2659-2668. PubMed ID: 36622444
    [Abstract] [Full Text] [Related]

  • 30. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.
    Wu D, Chen J, Ling C, Chen Z, Fan J, Sun Q, Meng Q, Liu X.
    Nephron; 2021 Aug; 145(4):415-427. PubMed ID: 33873197
    [Abstract] [Full Text] [Related]

  • 31. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
    Phillips EH, Westwood JP, Brocklebank V, Wong EK, Tellez JO, Marchbank KJ, McGuckin S, Gale DP, Connolly J, Goodship TH, Kavanagh D, Scully MA.
    J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
    [Abstract] [Full Text] [Related]

  • 32.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Martín B, Smith RJH.
    ; 1993 Jan. PubMed ID: 20301598
    [Abstract] [Full Text] [Related]

  • 33. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S.
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [Abstract] [Full Text] [Related]

  • 34. [Analysis of variants in complement genes in Han Chinese children with atypical hemolytic uremic syndrome].
    Yi CL, Zhao F, Qiu HZ, Wang LM, Huang J, Nie XJ, Yu ZH.
    Zhonghua Er Ke Za Zhi; 2017 Aug 02; 55(8):624-627. PubMed ID: 28822440
    [Abstract] [Full Text] [Related]

  • 35. Overactivity of Alternative Pathway Convertases in Patients With Complement-Mediated Renal Diseases.
    Michels MAHM, van de Kar NCAJ, Okrój M, Blom AM, van Kraaij SAW, Volokhina EB, van den Heuvel LPWJ.
    Front Immunol; 2018 Aug 02; 9():612. PubMed ID: 29670616
    [Abstract] [Full Text] [Related]

  • 36. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.
    Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T.
    Int J Hematol; 2014 Nov 02; 100(5):437-42. PubMed ID: 25135378
    [Abstract] [Full Text] [Related]

  • 37. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
    Pollack S, Eisenstein I, Mory A, Paperna T, Ofir A, Baris-Feldman H, Weiss K, Veszeli N, Csuka D, Shemer R, Glaser F, Prohászka Z, Magen D.
    Front Immunol; 2021 Nov 02; 12():608604. PubMed ID: 34248927
    [Abstract] [Full Text] [Related]

  • 38. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M, Donadelli R, Remuzzi G.
    Pediatr Nephrol; 2019 Aug 02; 34(8):1311-1323. PubMed ID: 29948306
    [Abstract] [Full Text] [Related]

  • 39. Diseases of complement dysregulation-an overview.
    Wong EKS, Kavanagh D.
    Semin Immunopathol; 2018 Jan 02; 40(1):49-64. PubMed ID: 29327071
    [Abstract] [Full Text] [Related]

  • 40. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J, Berenberg-Goßler L, Wu K, Beringer O, Kropp F, Müller D, Thumfart J.
    Pediatr Nephrol; 2018 Dec 02; 33(12):2289-2298. PubMed ID: 30238151
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.